NCT00997087View on ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder

PHASE2TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Obsessive Compulsive Disorder
Interventions
DRUG

Flumazenil

Sublingual daily

Trial Locations (1)

35215

James G. Sullivan, MD, Birmingham

Sponsors
All Listed Sponsors
lead

Parkway Medical Center

OTHER